These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17403828)

  • 21. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2012 Jun; 36(5):345-8. PubMed ID: 22582270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses.
    Mordal J; Holm B; Mørland J; Bramness JG
    J Clin Psychopharmacol; 2010 Aug; 30(4):455-9. PubMed ID: 20631563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine drug testing for social service agencies. A Canadian experience.
    Fraser AD
    Clin Lab Med; 1998 Dec; 18(4):705-11. PubMed ID: 9891609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine testing in the detection of drugs of abuse.
    Schwartz RH
    Arch Intern Med; 1988 Nov; 148(11):2407-12. PubMed ID: 3056313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Youth substance use and abuse: challenges and strategies for identification and intervention.
    Leslie K
    CMAJ; 2008 Jan; 178(2):145-8. PubMed ID: 18195284
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychiatric patients in the pediatric emergency department undergoing routine urine toxicology screens for medical clearance: results and use.
    Fortu JM; Kim IK; Cooper A; Condra C; Lorenz DJ; Pierce MC
    Pediatr Emerg Care; 2009 Jun; 25(6):387-92. PubMed ID: 19458561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders.
    Skipper GE; Weinmann W; Thierauf A; Schaefer P; Wiesbeck G; Allen JP; Miller M; Wurst FM
    Alcohol Alcohol; 2004; 39(5):445-9. PubMed ID: 15289206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the multiple drugs immunoassay test for rapid detection of drug abuse in postmortem urine.
    Srisont S; Chirachariyavej T; Peonim AV
    J Med Assoc Thai; 2010 Nov; 93(11):1301-9. PubMed ID: 21114210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategy for increasing detection rates of drug and alcohol abuse in paediatric emergency departments.
    Kozer E; Bar-Hamburger R; Rosenfeld N; Dalal I; Landu O; Fainmesser P; Ben-Yehuda Y; Berkovitch M
    Acta Paediatr; 2009 Oct; 98(10):1637-40. PubMed ID: 19555445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.
    Tomaszewski C; Runge J; Gibbs M; Colucciello S; Price M
    J Emerg Med; 2005 May; 28(4):389-94. PubMed ID: 15837018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups.
    Lin CN; Nelson GJ; McMillin GA
    J Anal Toxicol; 2013; 37(1):30-6. PubMed ID: 23144203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.